358376-04-2 Usage
Chemical class
Belongs to the benzothiazepine class of compounds.
Structural features
Contains a unique combination of bromine, butyl, and phenyl groups.
Potential applications
Likely to have diverse and potentially valuable properties, including potential applications in the pharmaceutical industry.
Biological activities
Further research and testing are needed to fully understand its potential uses and effects.
Solubility
The solubility of 1,5-Benzothiazepin-8-ol,
7-bromo-3,3-dibutyl-2,3,4,5-tetrahydro-5-phenyl-, 1,1-dioxide in water and other solvents is not mentioned in the provided material.
Stability
The stability of 1,5-Benzothiazepin-8-ol,
7-bromo-3,3-dibutyl-2,3,4,5-tetrahydro-5-phenyl-, 1,1-dioxide under different conditions (e.g., temperature, pH, light exposure) is not mentioned in the provided material.
Toxicity
The toxicity of 1,5-Benzothiazepin-8-ol,
7-bromo-3,3-dibutyl-2,3,4,5-tetrahydro-5-phenyl-, 1,1-dioxide and its potential effects on human health and the environment are not mentioned in the provided material.
Synthesis
The synthesis method for 1,5-Benzothiazepin-8-ol,
7-bromo-3,3-dibutyl-2,3,4,5-tetrahydro-5-phenyl-, 1,1-dioxide is not provided in the material.
Purity
The purity of the compound and any potential impurities or side products are not mentioned in the provided material.
Analytical methods
The analytical methods used to characterize and confirm the structure of 1,5-Benzothiazepin-8-ol,
7-bromo-3,3-dibutyl-2,3,4,5-tetrahydro-5-phenyl-, 1,1-dioxide are not mentioned in the provided material.
Check Digit Verification of cas no
The CAS Registry Mumber 358376-04-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,8,3,7 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 358376-04:
(8*3)+(7*5)+(6*8)+(5*3)+(4*7)+(3*6)+(2*0)+(1*4)=172
172 % 10 = 2
So 358376-04-2 is a valid CAS Registry Number.
358376-04-2Relevant academic research and scientific papers
BENZOTHIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS
-
Paragraph 0509-0510; 0800-0802, (2020/08/20)
The invention relates to 1,5-benzothiazepine derivatives of formula (I). These compounds are bile acid modulators having apical sodium-dependent bile acid transporter (ASBT) and/or liver bile acid transport (LBAT) inhibitory activity. The invention also r
BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS
-
Paragraph 0578-0580, (2019/12/24)
The invention relates to 1,5-benzothiazepine and 1,2,5-benzothiadiazepine derivatives of formula (I). These compounds are bile acid modulators having apical sodium-dependent bile acid transporter (ASBT) and/or liver bile acid transport (LBAT) inhibitory activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment of cardiovascular diseases, fatty acid metabolism and glucose utilization disorders, gastrointestinal diseases and liver diseases.
